FDA Announces Draft Guidance on Cancer Clinical Trial Eligibility Criteria

Summary

The FDA has released a draft guidance outlining the eligibility criteria for cancer clinical trials, aiming to broaden trial participation and improve the understanding of treatment benefits and risks for patients with organ dysfunction or prior malignancies.